AR053715A1 - HPV MULTIVALENT VACCINE - Google Patents

HPV MULTIVALENT VACCINE

Info

Publication number
AR053715A1
AR053715A1 ARP060101618A ARP060101618A AR053715A1 AR 053715 A1 AR053715 A1 AR 053715A1 AR P060101618 A ARP060101618 A AR P060101618A AR P060101618 A ARP060101618 A AR P060101618A AR 053715 A1 AR053715 A1 AR 053715A1
Authority
AR
Argentina
Prior art keywords
hpv
multivalent vaccine
hpv multivalent
immunization
vaccines
Prior art date
Application number
ARP060101618A
Other languages
Spanish (es)
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/114,301 external-priority patent/US20050287161A1/en
Priority claimed from PCT/EP2005/006461 external-priority patent/WO2005123125A1/en
Priority claimed from US11/367,601 external-priority patent/US7858098B2/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of AR053715A1 publication Critical patent/AR053715A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/892—Reproductive system [uterus, ovaries, cervix, testes]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Abstract

Procedimientos y vacunas para tratar infecciones causadas por los papilomavirus humanos. Se ha determinado que la inmunizacion con partículas semejantes al virus VPH-16 y VPH-18 proporciona proteccion cruzada contra otros tipos de VPH.Procedures and vaccines to treat infections caused by human papillomaviruses. It has been determined that immunization with particles similar to the HPV-16 and HPV-18 virus provides cross protection against other types of HPV.

ARP060101618A 2005-04-26 2006-04-24 HPV MULTIVALENT VACCINE AR053715A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/114,301 US20050287161A1 (en) 2002-12-20 2005-04-26 Vaccine
PCT/EP2005/006461 WO2005123125A1 (en) 2004-06-16 2005-06-14 Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
US11/367,601 US7858098B2 (en) 2002-12-20 2005-12-16 Vaccine

Publications (1)

Publication Number Publication Date
AR053715A1 true AR053715A1 (en) 2007-05-16

Family

ID=37199195

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101618A AR053715A1 (en) 2005-04-26 2006-04-24 HPV MULTIVALENT VACCINE

Country Status (12)

Country Link
EP (1) EP1879614A2 (en)
JP (1) JP2008539182A (en)
KR (1) KR20080005583A (en)
AR (1) AR053715A1 (en)
AU (1) AU2006239471A1 (en)
CA (1) CA2606206A1 (en)
EA (1) EA013325B1 (en)
MX (1) MX2007013475A (en)
NO (1) NO20075185L (en)
SG (1) SG159529A1 (en)
UY (1) UY29499A1 (en)
WO (1) WO2006114273A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011013566A (en) * 2009-06-19 2012-06-28 Eyegene Inc Vaccine for cervical cancer.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US6908613B2 (en) * 2000-06-21 2005-06-21 Medimmune, Inc. Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
EA200701633A1 (en) * 2002-12-20 2007-12-28 Глаксосмитклайн Байолоджикалс С.А. VACCINE BASED ON VIRUS-LIKE PARTICLES OF THE HUMAN PAPILLOMA VIRUS 16 AND HUMAN PAPILE VOLUS 18 L1
BRPI0512042B8 (en) * 2004-06-16 2021-05-25 Glaxosmithkline Biologicals Sa immunogenic composition, vaccine, use of a composition or vaccine, method for producing an immunogenic composition, and, use of vlps or capsomeres of hpv 16 and 18 with vlps or capsomeres of at least one other hpv of the cancer-causing type

Also Published As

Publication number Publication date
KR20080005583A (en) 2008-01-14
WO2006114273A3 (en) 2007-03-15
CA2606206A1 (en) 2006-11-02
EA200702077A1 (en) 2008-04-28
AU2006239471A1 (en) 2006-11-02
EP1879614A2 (en) 2008-01-23
SG159529A1 (en) 2010-03-30
UY29499A1 (en) 2006-11-30
JP2008539182A (en) 2008-11-13
MX2007013475A (en) 2008-04-02
EA013325B1 (en) 2010-04-30
NO20075185L (en) 2008-01-25
WO2006114273A2 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
ECSP055869A (en) HPV-16 AND -18 L1 VLP VACCINE
IL186611A0 (en) Vaccine against pandemic strains of influenza viruses
IL198466A (en) Use of dengue fever vaccinal viruses for the manufacture of a monovalent vaccine and a tetravalent vaccine for immunization against dengue fever virus and immunization kits against dengue fever virus comprising said vaccines
EA201190327A1 (en) NEW CONSTRUCTIONS OF HUMAN PAPILLOMA VIRUS PROTECTION (HPV) AND THEIR APPLICATION IN THE PREVENTION OF DISEASE CAUSED BY HPV
ECSP045300A (en) VIRAL ANTIGENS
PT2121011E (en) Vaccines including antigen from four strains of influenza virus
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
WO2007121894A3 (en) Hpv-18-based papillomavirus vaccine
AR080111A1 (en) IMMUNIZATION METHODS AND COMPOSITIONS
WO2007121895A3 (en) Hpv-16-based papillomavirus vaccine
WO2011079073A3 (en) Herpes simplex virus vaccines
BR112018011310A2 (en) A mutant of human papillomavirus type 58 L1 protein
WO2019099723A3 (en) Materials and methods relating to immunogenic epitopes from human papillomavirus
BRPI0810951B8 (en) hpv6 l1 protein, polynucleotide, vector, cell, virus-like particle (vlp) hpv6, method for producing truncated hpv6 l1 protein, vaccine for prevention of condyloma acuminatum or hpv infections, use of truncated hpv6 l1 protein, method for prevention of condyloma acuminata or hpv infections, method of obtaining a vlp of a hpv6 l1 protein, and method of producing a vaccine for the prevention of condyloma acuminatum or hpv infections
BR112018011331A2 (en) human papillomavirus l1 protein mutant type 11
ATE549031T1 (en) VACCINE COMPOSITION FOR PREVENTING CMV INFECTIONS
AR054259A1 (en) VACCINE AGAINST HUMAN PAPILOMA VIRUS (HPV)
EA201400235A1 (en) VACCINES AGAINST FLU BASED ON H5
AR053715A1 (en) HPV MULTIVALENT VACCINE
PE20230349A1 (en) VACCINES FOR RECURRENT RESPIRATORY PAPILLOMATOSIS AND METHODS OF USING THESE
MX2014014878A (en) Combination of therapeutic agents for treating hcv infection.
AR041515A1 (en) DNA VACCINE AGAINST HUMAN PAPILOMA VIRUS
UY31574A1 (en) VACCINES AGAINST MALARIA
TW200716169A (en) Vaccine
BR112012022680A2 (en) methods to protect a canine animal against disease, and, use of a canine influenza virus vaccine

Legal Events

Date Code Title Description
FA Abandonment or withdrawal